Funding for this research was provided by:
Taipei Tzu Chi Hospital (TCRD-TPE-109-53, TCRD-TPE-111-19)
Buddhist Tzu Chi Medical Foundation (TCMF-A 109-05 (111))
Received: 1 September 2022
Accepted: 26 November 2022
First Online: 4 December 2022
: This single-center, retrospective cohort study was approved by the Institutional Review Board of Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, and New Taipei City, Taiwan, on August 10, 2022 (Protocol No.:11-X-112). This study was conducted in accordance with the guidelines of the amended Declaration of Helsinki. The study protocol was reviewed and an informed consent waiver was obtained from the Institutional Review Board. The application of bio-specimens in this study was reviewed and approved by the Biobank Ethics Committee (Application No: Tzubiobank 2022-01).
: For this retrospective cohort study, an informed consent waiver was received from the IRB and patient privacy rights were observed regarding any individual data in any form (including individual details, images, or videos).
: The authors declare that they have no competing interests.